Penbugs
Coronavirus

COVID19: Trails for Russia’s vaccine to begin in India in few days

The Russian Direct Investment Fund (RDIF) and Dr Reddy’s Laboratories Limited, a global pharmaceutical company headquartered in India, have agreed to cooperate on clinical trials and distribution of Sputnik V COVID-19 vaccine in India.

“Indian trials of the Sputnik-V vaccine candidate, being developed by Russia’s sovereign wealth fund, will enroll 1,000-2,000 participants and be conducted at multiple government and private hospitals across the country.

“We want to get to the first step – which is the commencement of the clinical trials by getting the necessary approvals from the Indian regulators – within the next few weeks,” Deepak Sapra, CEO for API and pharmaceutical services at Dr Reddy’s, told Reuters.

Sapra added that they will identify potential manufacturers in India. The vaccine will have the inputs of both the Indian as well as Russian company.

Related posts

மக்கள் நீதி மய்யம் வேட்பாளர் சந்தோஷ் பாபுவிற்கு கொரோனா தொற்று

Penbugs

தமிழகத்தில் இன்று ஒரே நாளில் 508 பேருக்கு கொரோனா உறுதி செய்யப்பட்டுள்ளது!

Penbugs

தமிழகத்தில் இன்று ஒரே நாளில் 2212 பேர் டிஸ்சார்ஜ்

Penbugs

Unlock 5.0: Guidelines issued on September 30 to remain in force till November 30

Penbugs

செய்திவாசிப்பாளர் வரதராஜன் மீது நடவடிக்கை!

Penbugs

தமிழகத்தில் புதிதாக 477 பேருக்கு கொரோனா தொற்று….!

Kesavan Madumathy

After donating to FEFSI, Sivakarthikeyan donates 25 Lakhs to CM relief fund

Penbugs

Chhattisgarh CM orders suspend rape accused IAS officer

Penbugs

COVID19: Punjab becomes 2nd state to extend Coronavirus lockdown

Penbugs

தமிழகத்தில் 771 பேருக்கு கொரோனா

Penbugs

COVID19: 77 new positive cases in Tamil Nadu

Penbugs

Leave a Comment